Cargando…
Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
Autores principales: | Lim, Cho A, Lee, Hyun Soon, Yoon, Songuk, Kim, Eun Jung, Seo, Jang Won, Koo, Ja-Ryong, Baek, Seon Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995482/ https://www.ncbi.nlm.nih.gov/pubmed/35286791 http://dx.doi.org/10.23876/j.krcp.21.308 |
Ejemplares similares
-
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021) -
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Maas, Rutger J., et al.
Publicado: (2021) -
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
por: Matsubara, Akihiro, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)